IN HB1150 | 2017 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2017 - 25% progression, died in committee
Action: 2017-01-09 - First reading: referred to Committee on Public Health
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription drug cost reporting. Requires the office of the secretary of family and social services to identify any prescription drug under the Medicaid program for which the annual wholesale cost or the per course cost of treatment of the drug is at least $10,000, and directs the office to notify the manufacturer that the manufacturer is required to prepare a report on the drug to the drug utilization review board (board). Specifies requirements of the report. Authorizes the board to request additional information, establish forms, and specify other requirements that a manufacturer must meet in the filing of the report.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription drug cost reporting. Requires the office of the secretary of family and social services to identify any prescription drug under the Medicaid program for which the annual wholesale cost or the per course cost of treatment of the drug is at least $10,000, and directs the office to notify the manufacturer that the manufacturer is required to prepare a report on the drug to the drug utilization review board (board). Specifies requirements of the report. Authorizes the board to request additional information, establish forms, and specify other requirements that a manufacturer must meet in the filing of the report.

Sponsors


History

DateChamberAction
2017-01-09HouseFirst reading: referred to Committee on Public Health
2017-01-09HouseAuthored by Representative Taylor J

Indiana State Sources


Bill Comments

feedback